Addyi is indicated for women under 65 suffering from —a condition characterized by a persistent or recurrent lack of sexual interest that causes significant personal or interpersonal distress. Crucially, for a diagnosis of HSDD, this lack of desire must not be attributable to a co-existing medical or psychiatric condition, relationship issues, or side effects from other medications. The Mechanism of Action: Rewiring the Brain
Below is an essay discussing the medical significance, mechanism, and controversies surrounding Addyi. Addyi 02mp4
Levels are modulated (specifically via 5-HT1A and 5-HT2A receptors) to reduce the "brakes" on sexual desire. Clinical Efficacy and Patient Safety Addyi is indicated for women under 65 suffering
Levels of these "pro-excitement" chemicals are increased to boost motivation and arousal. Levels are modulated (specifically via 5-HT1A and 5-HT2A
While the exact mechanism is not fully understood, Addyi is classified as a multifunctional serotonin agonist and antagonist (MSAA). It is thought to work by rebalancing neurotransmitters in the brain's prefrontal cortex: